US Stock MarketDetailed Quotes
CLDI Calidi Biotherapeutics
- 0.197
- +0.002+1.03%
Close Jun 18 16:00 ET
- 0.195
- -0.002-1.02%
Post 18:10 ET
12.65MMarket Cap-239P/E (TTM)
0.212High0.191Low1.55MVolume0.191Open0.195Pre Close312.20KTurnover3.42%Turnover RatioLossP/E (Static)64.19MShares13.79052wk High-0.87P/B8.94MFloat Cap0.14452wk Low--Dividend TTM45.39MShs Float13.790Historical High--Div YieldTTM10.77%Amplitude0.144Historical Low0.201Avg Price1Lot Size
About Calidi Biotherapeutics Company
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
Company Profile
SymbolCLDI
Company NameCalidi Biotherapeutics
Listing DateNov 17, 2022
Founded2014
CEOMr. Allan Camaisa
MarketAMEX
Employees41
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4475 Executive Drive,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-794-9600
Websitehttp://www.calidibio.com
Company Executives
- Name
- Position
- Salary
- Allan Camaisa
- Chief Executive Officer and Chairman of the Board
- 436.51K
- Wendy Pizarro
- Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer and Corporate Secretary
- 295.40K
- Dr. Boris Radoslavov Minev, M.D.
- President of Medical and Scientific Affairs and Interim Chief Medical Officer
- 400.10K
- Andrew C. Jackson
- Chief Financial Officer and Principal Accounting Officer
- --
- George K. Ng
- Director
- 731.34K
- James A. Schoeneck
- Independent Director
- 109.56K
- Alan R. Stewart
- Independent Director
- 120.56K
- Scott Leftwich
- Independent Director
- 179.89K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg